Bank of Nova Scotia’s Gossamer Bio GOSS Stock Holding History

Bank of Nova Scotia’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35,000	Closed	-$92K	–	1139
2025 Q3	$92K	Buy	+35,000	New	+$77.1K	﹤0.01%	1005

Other funds holding GOSS

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Bank of Nova Scotia's GOSS Position: Q4 2025 in Review

Bank of Nova Scotia sold out of Gossamer Bio (GOSS) in Q4 2025, closing a stake of 35,000 shares — an estimated $92K sold.

Bank of Nova Scotia first reported a position in GOSS in Q3 2025 and held it in 1 quarter. The position peaked at $92K in Q3 2025. 195 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

Bank of Nova Scotia reported no remaining Gossamer Bio position as of Q4 2025 after selling out during the quarter.
Bank of Nova Scotia sold 35,000 Gossamer Bio shares in Q4 2025, an estimated $92K.
Bank of Nova Scotia first reported a position in Gossamer Bio in Q3 2025 and held it in 1 quarter.
Bank of Nova Scotia's Gossamer Bio position peaked at $92K in Q3 2025.
195 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on Bank of Nova Scotia's 13F filing for Q4 2025, filed 13 Feb 2026.